These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1627975)

  • 1. Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.
    Mattingly G; Baker K; Zorumski CF; Figiel GS
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):145-51. PubMed ID: 1627975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy.
    Larsson HB
    Acta Neurol Scand Suppl; 1995; 159():1-44. PubMed ID: 7625161
    [No Abstract]   [Full Text] [Related]  

  • 5. Electroconvulsive therapy for post-stroke depressed geriatric patients.
    Currier MB; Murray GB; Welch CC
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):140-4. PubMed ID: 1627974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric symptoms and mental changes as major features of multiple sclerosis.
    Sanders EA; van Lieshout HB
    Clin Neurol Neurosurg; 1992; 94 Suppl():S144-6. PubMed ID: 1320493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS.
    Mattioli F; Cappa SF; Cominelli C; Capra R; Marcianoc N; Gasparotti R
    Acta Neurol Scand; 1993 Jun; 87(6):465-8. PubMed ID: 8356876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy in patients with multiple sclerosis.
    Rasmussen KG; Keegan BM
    J ECT; 2007 Sep; 23(3):179-80. PubMed ID: 17804994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
    Urban-Kowalczyk M; Rudecki T; Wróblewski D; Smigielski J; Kałużyńska O; Rabe-Jabłońska J
    Neurocase; 2014 Aug; 20(4):452-5. PubMed ID: 23679561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging in multiple sclerosis: an overview.
    Colosimo M; Amatruda A; Cioffi RP
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracranial tumor-like lesions in children and young adults with multiple sclerosis].
    Einig M; Higer HP; Mauz M; Ernst JP
    Rofo; 1992 Oct; 157(4):384-9. PubMed ID: 1391842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.
    Thompson AJ; Miller D; Youl B; MacManus D; Moore S; Kingsley D; Kendall B; Feinstein A; McDonald WI
    Neurology; 1992 Jan; 42(1):60-3. PubMed ID: 1734325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
    Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
    Nomura M; Suzumura A; Anno H; Miyata E; Koga S; Yamamoto H
    Rinsho Shinkeigaku; 1995 Mar; 35(3):225-30. PubMed ID: 7614741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECT as a treatment for depression in Huntington's disease.
    Ranen NG; Peyser CE; Folstein SE
    J Neuropsychiatry Clin Neurosci; 1994; 6(2):154-9. PubMed ID: 8044037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of ECT in patients with head injury: a case series.
    Kant R; Coffey CE; Bogyi AM
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):32-7. PubMed ID: 9990553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.
    Paty DW; Li DK; Koopmans R
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):978. PubMed ID: 1431970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
    Gowin W; Weihe W; Appel C; Mariss G
    Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease.
    Baldwin RC; Simpson S
    J Affect Disord; 1997 Dec; 46(3):163-73. PubMed ID: 9547114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.